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Background: A gastroesophageal anastomotic fistula remains a potentially life-threatening post-esophagectomy
complication. To promote fistula closure, we developed a modified endoscopic method of trans-fistula drainage
with persistent negative pressure. In this study, we aimed to evaluate the efficacy of this endoscopic therapy.
Methods: Between June and November 2013, five male patients with post-surgical esophageal leakages who had
undergone trans-fistula drainage therapy were treated with the modified endoscopic trans-fistula negative pressure
drainage (E-TNPD) method. We placed a nasogastric silicone tube into the paraesophageal cavity through the fistula
and accomplished drainage of the infected effusion with continuous negative pressure, resulting in shrinkage of the
para-anastomotic cavity and eventual fistula closure. We withdrew the trans-fistula drainage when there were no
signs of leakage, as confirmed by esophagography. Final closure was confirmed by esophagography before the
patient was allowed to begin oral intake.
Results: E-TNPD was successful in all five patients. The median duration of drainage until tube removal was 34 days
(range: 18 to 81 days). The duration for Cases 1 to 4 was 18 to 28 days. Case 5 suffered from multiple separate leaks
at the anastomotic site and the gastric conduit. Complete restoration was achieved in 81 days for this patient. We
found that in general, the earlier that trans-fistula drainage was established, the shorter the duration of
hospitalization until complete defect closure.
Conclusions: E-TNPD provided reliable and convenient management of post-surgical gastroesophageal anastomotic
fistula and esophageal perforation. This method promoted fistula closure and prevented unnecessary repeated
endoscopic examinations, extra equipment and expense.
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Esophageal cancer is the eighth most common cancer
and the sixth leading cause of death from cancer world-
wide [1]. Gastroesophageal resection combined with
multimodal therapy regimens is the standard treatment
for resectable esophageal cancer. However, an anasto-
motic fistula remains a potentially life-threatening com-
plication post-esophagectomy, with an incidence ranging
from 3% to 25% [2-5]. Esophageal leakage can result in* Correspondence: chengjinfeng123@163.com
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unless otherwise stated.mediastinitis and subsequent sepsis and can lead to pro-
longed hospitalization. Possible treatment options must
accomplish drainage of the septic focus in the mediasti-
num and close the esophageal wall defect or the dehiscent
circular staple line of the anastomosis. The traditional
conservative method of treating the complication, consis-
ting of systemic antibiotics, conventional thoracic drainage
and thoracic irrigation, usually leads to increased duration
of hospitalization. Reoperation can achieve adequate de-
bridement and promote conventional drainage but is not
a reliable way to achieve fistula closure and is associated
with high morbidity and mortality. Several endoscopic
treatment options for repair of esophageal anastomotic
leakage have emerged to promote fistula closure,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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stents (SEMSs) and self-expanding plastic stents (SEPSs)
[6-8]. However, anastomotic leakage remains a challenge,
with few available treatment options.
Recently, endoscopic vacuum-assisted closure (E-VAC)
has been reported as an effective treatment for closure of
perforated diverticula and for intrathoracic and cervical
anastomotic leakages in the upper gastrointestinal tract
[9-11]. E-VAC involves placing polyurethane sponges
through a fistula tube into the infection cavity, followed by
application of an external vacuum through a transnasal
tube to remove purulent secretions and to induce the
formation of granulation tissue. To improve the feasibility
of E-VAC drainage, we developed a modified method to
accomplish trans-fistula drainage through a simple naso-
gastric tube without sponge placement or repeated gas-
troscopy. With simple equipment, we were able to achieve
the goals of sufficient drainage, control of the infection
source and prevention of further mediastinal contami-
nation with persistent negative pressure.
Herein we report our experience treating anastomotic
leakages in five esophageal cancer patients using endo-
scopic trans-fistula negative pressure drainage (E-TNPD).
The objectives of this study were to investigate whether
E-TNPD could work as a convenient and reliable method
of promoting post-esophagectomy fistula closure by im-
proving trans-fistula drainage and to establish an effective
complement to existing therapy.
Methods
Patients
Between June and November 2013, five male patients with
major post-surgical esophageal leakages who underwent
E-TNPD therapy at Beijing Cancer Hospital were enrolled
in this study. This study was approved by the Medical
Ethics Committee of Beijing Cancer Hospital. Written in-
formed consent was obtained from the patients before the
treatment. Three patients suffered from an intrathoracic
anastomotic fistula after Ivor–Lewis subtotal esophagec-
tomy, one patient suffered from perforation of a mid-
esophageal diverticulum post-esophagectomy and one
patient suffered from a cervical anastomotic fistula post
McKeown esophagectomy. Tumors were staged accordingTable 1 Characteristics of five patients who underwent endos
Age (years) Pathologically differentiated
Case 1 59 Poorly
Case 2 63 Well
Case 3 64 Moderately, poorly
Case 4 66 Moderately
Case 5 57 Poorly
aIvor–Lewis esophagectomy: combination of a laparotomy and a right thoracotomy
bMcKeown esophagectomy: total esophagectomy through right thoracotomy, laparto the TNM classification of the International Union
Against Cancer staging system. The characteristics of
these inpatients are shown in Table 1.
Diagnosis of leakage
Leakage of the anastomosis was clinically suspected
according to manifestations, based on fever or other signs
of thoracic infection, characteristics of chest-tube drainage
or incision infection. Leakage was clinically diagnosed as
contaminated thoracic drainage with precipitant. Sub-
sequently, the leakages were confirmed by esophago-
graphy or endoscopic examination. In particular, Case 1
suffered from a diverticulum perforation but not anasto-
motic fistula. The esophagography on post-operative day
(Pod) 9 showed no leakage for him. However, he suffered
hemorrhage from the esophageal artery stump and required
re-thoracotomy; an intraoperative exploration confirmed a
tiny diverticulum perforation, which was neglected during
the esophagectomy.
Traditional conservative treatment
When thoracic infection was confirmed based on con-
taminated thoracic drainage, a leak was highly suspected
and a double lumen tube system was immediately estab-
lished for irrigation. An intravenous catheter was passed
into the lumen of a conventional thoracic drainage tube
[12]. Irrigation fluid was introduced via the intravenous
catheter lumen, while the larger outer tube had multiple
side holes to provide drainage. The thoracic cavity was
flushed several times with irrigation fluids containing
gentamycin in saline to clear most of the pus. In accord-
ance with the empyema regimen, all patients received
intravenous antibiotics and were fed enteral nutrition via
a nasojejunal feeding tube.
Modified negative-pressure-assisted nasogastric drainage
Based on our previous experience of misplaced nasogastric
tubes through fistula sites into the thoracic cavity and on a
literature review, we designed the E-TNPD method to
clear infected secretions, shrinking the para-anastomotic
cavity and eventually allowing closure of the defect. Naso-
gastric drainage tube placement was performed with a
regular 9.5-mm-diameter endoscope (Olympus GIF-H260,copic trans-fistula drainage






with an intrathoracic subtotal esophagogastrostomy.
otomy and neck incision with a cervical anastomosis.
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defect was located, its size was estimated and the cavity was
flushed with an endowasher via the working channel of the
endoscope. Next, a nasogastric silicone tube (DRW-B;
BJ Dare Medical Equipment, Baoji, China) was introduced
with the grasper forceps into the paraesophageal cavity
through the leak site under endoscopic vision. Continuous
negative pressure of 25 mmHg was applied using a
vacuum pump. The tube itself filled the entire esophageal
defect immediately and the negative pressure evacuated
fluid secretions, greatly shrinking the fistula tube and
decreasing the cavity size. All endoscopic interventions
were performed without general anesthesia or sedation.
Results
Characteristics of patients
Patient characteristics are summarized in Table 1. We
employed E-TNPD treatment for five patients with post-
operative esophageal leakage. The patients’ ages ranged
from 57 to 66 years. All five patients had undergone surgi-
cal excision of esophageal cancer with esophageal-gastric
anastomosis. Patients 2 and 3 had intrathoracic anasto-
motic fistulae. Case 5 had intrathoracic fistulae with
concurrent remnant stomach leakage. Case 4 had cervicalFigure 1 Endoscopic images of esophageal leakage after esophagect
(D-F) Endoscopic images for Case 5. (A) Endoscopic detection of the esophag
and the thoracic tube could be detected endoscopically. The jejunal feeding t
para-anastomotic cavity (arrow). (B) The nasogastric tube was placed into the
adjusted for appropriate negative pressure. The leakage was obviously rec
and the nasogastric tube was in the para-anastomotic cavity (arrow); the c
healing. The anastomosis had some stenosis (asterisk) and the fistula had alre
Case 5. The jejunal feeding tube was in the gastric cavity (asterisk), and the fis
para-anastomotic cavity (E-TNPD). The jejunal feeding tube was in the gastric
cavity (arrow). (F) Endoscopic image of tiny leakage healing. The blind side ofanastomotic fistulae after a McKeown esophagectomy.
Case 1 suffered from mid-esophageal diverticulum perfo-
ration after esophagectomy.
Indications and timing of E-TNPD therapy
For all five patients, we endoscopically verified anasto-
motic leaks and E-TNPD was successfully accomplished.
Two patients underwent endoscopic drainage placement
(Case 1 on Pod 52 and Case 4 on Pod 35) after 34 and
28 days of irrigation, respectively, without any progress in
fistula healing. Case 1 experienced hemorrhage from an
esophageal artery stump and re-thoracotomy confirmed a
diverticulum perforation that had been neglected during
esophagectomy. On the basis of the successful experiences
for the two previous patients, we performed trans-fistula
drainage earlier for Cases 3 (on Pod 16) and 5 (on Pod 28).
Case 5 developed separate leaks on the circular staple line
of the anastomosis and on the body of the gastric conduit.
In this patient, we placed two drainage tubes into the dif-
ferent cavities. Case 2 suffered from persistent leakage and
concomitant chronic empyema, sepsis, severe continuous
diarrhea and subsequent acute renal failure. After hemofil-
tration therapy, we applied E-TNPD treatment for that
patient on Pod 95 (Table 2).omy and E-TNPD therapy. (A-C) Endoscopic images for Case 3.
eal leakage before E-TNPD therapy in Case 3. The defect was obvious
ube was in the gastric cavity (asterisk). There was a thoracic tube in the
para-anastomotic cavity (E-TNPD) and the thoracic tube was subsequently
overed. The jejunal feeding tube was in the gastric cavity (asterisk),
avity had already closed. (C) Endoscopic image after complete
ady healed (arrow). (D) Endoscopic detection of esophageal leakage for
tula was small (arrow). (E) The nasogastric tube was placed into the
cavity (asterisk), and the nasogastric tube was in the para-anastomotic
the fistula is shown magnified in the inset (arrow).














1 13 29 52 28
2 11 71 95 26
3 8 8 16 18
4 7 28 35 18
5 7 21 28 81
aA fistula was clinically diagnosed if there was contaminated thoracic
drainage with precipitant. Subsequently, the leakages were confirmed
with esophagography.
bIrrigation duration before E-TNPD.
cE-TNPD was trans-fistula tube placement and initiation of drainage.
dDuration post E-TNPD was the trans-fistula drainage period until
tube removal.
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All patients tolerated negative pressure and did not react
with arrhythmia, hemorrhage or hemodynamic compli-
cations. No patients complained of increased discomfort
resulting from the E-TNPD method or the continuous
negative pressure. No serious adverse complications as-
sociated with E-TNPD were noted. Once drainage was
established and the thoracic infection was controlled,
the thoracic drainage became clear within 2 to 3 weeks.
We gradually withdrew 5 cm of the trans-fistula tube
and placed a nasogastric tube into the gastric conduit
lumen as a normal gastrointestinal decompression tube
within 1 week of cessation of leakage. The courses of
E-TNPD treatment are listed in Table 2. When fistula
closure was confirmed by esophagography and pleuralFigure 2 Drainage volume of thoracic or nasogastric tube before and
thoracic drainage volume was 252 ml (range: 201 to 283 ml) with purulent ef
drainage volume markedly decreased to 94 ml per day (range: 9 to 163 ml). (
tube mean drainage decreased from 202 ml per day (range: 124 to 311 ml) to
mean nasogastric tube drainage increased from 168 ml to 252 ml, but the mempyema was completely controlled, the patient was
allowed to begin oral intake.
Outcome of E-TNPD treatment
Combined with systemic antibiotics and thoracic irriga-
tion, nasogastric trans-fistula drainage promoted fistula
closure. In all five patients, complete closure of the fis-
tula was achieved without any procedure-related compli-
cations (Figures 1 and 2).
In all five patients, thoracic drainage was found to be
contaminated and plural empyema developed, with lea-
kage confirmed on Pods 7 to 13. Patients underwent tho-
racic irrigation for a median duration of 31 days (range: 8
to 71 days) without signs of improvement. After establish-
ment of E-TNPD, fistula closure was promoted. The me-
dian duration of trans-fistula drainage until tube removal
for all patients was 34 days (range: 18 to 81 days), with a
duration of 18 to 28 days for Cases 1 to 4. Case 5 suffered
from multiple separate leaks on the anastomotic circle
and the gastric conduit. This patient experienced com-
plete healing in 81 days. With the exception of Case 5,
earlier administration of E-TNPD resulted in shorter hos-
pitalization after achieving complete defect closure. All
five patients suffered from severe empyema before trans-
fistula drainage therapy intervention, with a mean thoracic
drainage volume of 252 ml per day (range: 201 to 283 ml),
with purulent effusion flushed by thoracic irrigation. After
trans-fistula drainage therapy, the mean volume of thor-
acic drainage decreased markedly to 94 ml per day (range:
9 to 163 ml), and subsequently transformed to normal
effusion without pus. Meanwhile, nasogastric tube mean
drainage decreased from 202 ml per day (range: 124 topost E-TNPD. (A) Before the E-TNPD therapy intervention, the median
fusion. After institution of the E-TNPD therapy, the median thoracic
B) E-TNPD promoted resolution of nasogastric tube drainage. Nasogastric
115 ml per day (range: 63 to 176 ml) for Cases 1 to 4. For Case 5, the
ean thoracic drainage decreased from 283 ml to 163 ml. Vol, volume.
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http://www.wjso.com/content/12/1/240311 ml) to 115 ml per day (range: 63 to 176 ml) for Cases
1 to 4. For Case 5, mean nasogastric tube drainage in-
creased from 168 ml to 252 ml, but the patient’s mean
thoracic drainage decreased from 283 ml to 163 ml.
Consent
Written informed consent was obtained from the patients
before each operation.
Discussion
Esophageal anastomotic leakage is a challenging condition
for both intrathoracic and cervical anastomoses, and there
is no current consensus on the best treatment methods.
Although several methods, including surgical re-explo-
ration and/or conservative approaches, have been per-
formed, the rate of treatment failure remains high.
Because the paraesophageal cavity is difficult to reach with
conventional drainage, para-fistula inflammation is diffi-
cult to control and leakage defects result in prolonged
hospitalization. To address these problems, we developed
a modified negative-pressure-assisted trans-fistula method
to achieve adequate drainage. This method allows ten-
sion-free healing at the leakage site and simultaneously
promotes the formation of granulation tissue in the cavity.
A variety of endoscopic techniques have allowed more
accurate assessment and management of anastomotic
disruption, including clipping, cyanoacrylate glue and
SEMS/SEPS. All of these approaches share the primary
therapeutic goal of sealing the leakage. Recently, Lenzen
et al. [10] and Brangewitz and colleagues [11] reported
that E-VAC was an effective treatment for leakage and
perforations. However, E-VAC can be inconvenient and
the method can be improved. Transoral endoscopic
placement of a sponge into a leak is technically deman-
ding and the size of the defect must match the sponge.
Moreover, patients must undergo repeated gastroscopy
for sponge exchange.
We developed the E-TNPD method to allow easy access
to the infected paraesophageal cavity and rapid removal of
infected tissue with persistent negative pressure. In this
case series, E-TNPD was a reliable method of draining the
para-anastomotic abscess cavity, which is a great challenge
with conventional thoracic drainage. It remains uncontro-
versial that sufficient drainage eradicates local infection,
prevents further contamination and controls sepsis. In our
cohort, we adopted E-TNPD on Pods 16 to 95 after
conservative therapy for 8 to 71 days without signs of
improvement. In general, thoracic and nasogastric tube
drainage obviously decreased after E-TNPD was estab-
lished (Figure 1). This decrease indicates that thoracic
purulent effusion and reflux infective effusion from the
para-fistula cavity were both gradually controlled. For
Cases 1 to 4, the total time to achieve defect closure was
18 to 28 days. Even in Case 5, with multiple leaks, defectsclosed in 81 days. The mean nasogastric tube drainage
volume increased for this patient, partly because of the
prolonged duration of the persistent nasogastric tube
drainage, but the patient’s thoracic drainage markedly de-
creased. E-TNPD is a reliable and effective method to con-
trol contamination in the mediastinum and to promote
the recovery process. We also found that generally, the
earlier that E-TNPD was instituted, the more effective it
was. Cases 1 and 4 had drainage established on Pod 52
and Pod 35, respectively, and their fistulae closed in 28
and 18 days, respectively. Cases 2 and 3 had drainage
established on Pod 95 and Pod 16, respectively, and their
fistulae closed in 26 and 18 days, respectively. For Case 5,
multiple leaks were drained, beginning on Pod 28, and
pleural empyema was rapidly controlled, with the fistula
closing in 81 days.
In our cohort, we applied E-TNPD for diverse leak-
ages, including anastomotic circle fistula (thoracic and
cervical anastomoses), gastric conduit leakage and mid-
esophageal diverticulum perforation. In all of these lo-
cations, E-TNPD was technically comparatively easy to
perform. After E-TNPD, repeated endoscopic exami-
nation was not necessary. Stenting requires technical
expertise, especially for cervical anastomosis leakage. In
addition, the E-TNPD method resulted in a significantly
higher closure rate and fewer strictures in patients with
intrathoracic leaks compared with the SEMS/SEPS
methods [13]. The E-TNPD method can be used to treat
leakages over a broad post-operative timeframe. When
feasible, E-TNPD was instituted as early as Pod 16 in
our cohort. Drainage could also be instituted on Pod 95
for persistent empyema and delayed fistula diagnosis. In
addition, Case 1 suffered perforation of a concomitant
mid-esophageal diverticulum, Case 4 suffered from a
cervical fistula with mediastinal leakage, and Case 5 suf-
fered multiple leakages on the anastomotic circle and
the conduit body. All of these patients were treated with
E-TNPD and eventually benefited from this treatment.
Furthermore, E-TNPD therapy can treat narrow leak-
ages, in which sponge placement would be impossible.
E-TNPD should be considered for diverse indications
and is acceptable with various timings, fistula types and
surrounding situations.
Conclusions
In conclusion, we found that E-TNPD was a reliable and
effective method for managing post-surgical gastroeso-
phageal anastomotic fistula and esophageal perforation.
E-TNPD promoted fistula closure and was effective in dif-
ferent leakage locations, post-surgical times, fistula types
and surrounding situations. Because there is currently no
standard management strategy applicable to all leakages,
E-TNPD may be an effective way to complement the
existing anastomotic fistula therapy after esophagectomy.
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